| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Bmp2 ELISA kit; Bmp-2Bone morphogenetic protein 2 ELISA kit; BMP-2 ELISA kit; Bone morphogenetic protein 2A ELISA kit; BMP-2A ELISA kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, tissue homogenates |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
Bone morphogenetic protein 2 (BMP2) is a biological molecule commonly studied in signal transduction research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: P49001
Biological context
Researchers often monitor Bone morphogenetic protein 2 in serum, plasma, and tissue homogenates to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in Bone morphogenetic protein 2 may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, Bone morphogenetic protein 2 may also appear under names such as Bmp2 and Bmp-2Bone morphogenetic protein 2. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Bone morphogenetic protein 2 participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
The mechanism of patchouli alcohol in treating IBS-D based on BMP-Smad pathway
Y Lu, C Huang, S Huang, T Li, W Chen, S Yi,Biomedicine & Pharmacotherapy,2025
Three Birds, One Stone: An Osteo-Microenvironment Stage-Regulative Scaffold for Bone Defect Repair through Modulating Early Osteo-Immunomodulation, Middle Neovascularization, and Later Osteogenesis
Y Yuan,Advanced science,2023
Parallel Chondrogenesis and Osteogenesis Tissue Morphogenesis in Muscle Tissue via Combinations of TGF-β Supergene Family Members
F Xiong,Cartilage,2023
Molecular mechanisms of interrod spacing-mediated osseointegration via modulating inflammatory response and osteogenic differentiation
M Yu,Chemical Engineering Journal,2022
The Toxicity and Antibacterial Effects of Povidone‐Iodine Irrigation in Fracture Surgery
D Wang,Orthopaedic Surgery,2022
Ischemia Injury: A New Method Accelerates Bone Healing in a Rat Tibia Fracture Model
Yang Liu, et al,BioMed Research International,2019
Psoralidin, a prenylated coumestan, as a novel anti-osteoporosis candidate to enhance bone formation of osteoblasts andDecrease bone resorption of osteoclasts
Yuankun Zhai.et al,European Journal of Pharmacology,2017